SynCardia Total Artificial Heart Professional Papers Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe. Content from this campaign Health & Healthcare U.S. Heart Surgeons Accept Only 34% of Available Donor Hearts for Transplant Tuesday, March 24, 2015 - 09:55 Health & Healthcare Medical Journal Describes 2 Consecutive SynCardia Total Artificial Heart Patients Bridged to Dual Heart-Kidney Transplants Thursday, March 12, 2015 - 13:30 Health & Healthcare Patients Supported for More Than 1 Year by the SynCardia Total Artificial Heart Experienced Acceptable Outcomes, Concludes International Study Tuesday, February 17, 2015 - 12:45 Health & Healthcare 3D Virtual Implantation Demonstrated that 19-Year-Old Female Could be Successfully Bridged to Transplant with the SynCardia Total Artificial Heart Tuesday, November 4, 2014 - 10:00 More from SynCardia Systems, Inc. SynCardia Awards and Recognition SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE... SynCardia Systems, Inc. SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE... SynCardia Total Artificial Heart Patients in the News Highest bridge to human heart transplant rate of any approved heart device, 79% Over 1,350 implants account for nearly 400 patient years on the... SynCardia temporary Total Artificial Heart The SynCardia Total Artificial Heart is the world's first & only FDA, Health Canada and CE approved Artificial Heart. SynCardia Systems, Inc. Regulatiory and Approvals FDA, CE Mark and Health Canada Approvals of SynCardia Systems, Inc. Devices SynCardia Total Artificial Heart Professional Papers Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe. Artificial Heart For patients suffering from end-stage biventricular (both sides) heart failure, a donor heart transplant is the standard of care. However, not all... Scholarships at SynCardia Systems, Inc. The Anna Salazar Memorial Engineering Scholarship, funded by SynCardia Systems, Inc., seeks to support female University of Arizona College of...
Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe.
SynCardia Awards and Recognition SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...
SynCardia Systems, Inc. SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...
SynCardia Total Artificial Heart Patients in the News Highest bridge to human heart transplant rate of any approved heart device, 79% Over 1,350 implants account for nearly 400 patient years on the...
SynCardia temporary Total Artificial Heart The SynCardia Total Artificial Heart is the world's first & only FDA, Health Canada and CE approved Artificial Heart.
SynCardia Systems, Inc. Regulatiory and Approvals FDA, CE Mark and Health Canada Approvals of SynCardia Systems, Inc. Devices
SynCardia Total Artificial Heart Professional Papers Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe.
Artificial Heart For patients suffering from end-stage biventricular (both sides) heart failure, a donor heart transplant is the standard of care. However, not all...
Scholarships at SynCardia Systems, Inc. The Anna Salazar Memorial Engineering Scholarship, funded by SynCardia Systems, Inc., seeks to support female University of Arizona College of...
